Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2017-06-28

AUTHORS

Hideki Kato, Masaomi Nangaku, Hideki Hirakata, Takashi Wada, Terumasa Hayashi, Hiroshi Sato, Yasushi Yamazaki, Takao Masaki, Tatsuo Kagimura, Hiroyasu Yamamoto, Hiroki Hase, Masahiro Kamouchi, Enyu Imai, Kyoichi Mizuno, Manabu Iwasaki, Tadao Akizawa, Yoshiharu Tsubakihara, Shoichi Maruyama, Ichiei Narita

ABSTRACT

BackgroundRenal anemia is an important complication in non-dialysis chronic kidney disease (CKD) patients as well as in dialysis patients. Although recombinant human erythropoietin has dramatically improved prognosis and quality of life in these patients, there have been issues among non-dialysis CKD patients who exhibit hyporesponsiveness to erythropoiesis-stimulating agent (ESA). The causes and definition of ESA hyporesponsiveness, as well as the incidence of renal and cardiovascular disease (CVD) events in such patients, are yet to be clarified.MethodsThis ongoing trial is a multicenter, prospective, observational study of non-dialysis CKD patients with renal anemia. The primary objective is to survey the current realities of the therapy with ESA in Japan and evaluate the correlation between hyporesponsiveness to darbepoetin alfa and CKD progression. The secondary objective is to investigate relationship between ESA hyporesponsiveness and CVD events based on the clinical situation in Japan, and to explore an ESA response index.ResultsThe subjects consist of CKD patients with estimated glomerular filtration rate (eGFR) below 60 mL/min/1.73 m2 who present renal anemia. The target number of registered cases is 2000 patients, based on estimates of incidences of renal and CVD events from past studies. Renal function and CVD events will be observed for 96 weeks after the initiation of darbepoetin alfa administration. Definitions of ESA hyporesponsiveness will also be investigated.ConclusionBy clarifying markers and factors involved in ESA hyporesponsiveness and their relationships with renal and CVD events, this ongoing study aims to improve evidence-based therapies for renal anemia in non-dialysis CKD patients. More... »

PAGES

78-84

Journal

TITLE

Clinical and Experimental Nephrology

ISSUE

1

VOLUME

22

Author Affiliations

  • Division of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo, 113-8655, Tokyo, Japan
  • Fukuoka Renal Clinic, Fukuoka, Fukuoka, Japan
  • Department of Nephrology and Laboratory Medicine, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan
  • Department of Kidney Disease and Hypertension, Osaka General Medical Centre, Sumiyoshi, Osaka, Japan
  • Division of Clinical Pharmacology and Therapeutics, Tohoku University Graduate School of Pharmaceutical Sciences and Faculty of Pharmaceutical Sciences, Sendai, Miyagi, Japan
  • Department of Nephrology and Rheumatology, Kagawa Prefectural Central Hospital, Takamatsu, Kagawa, Japan
  • Department of Nephrology, Hiroshima University Hospital, Hiroshima, Hiroshima, Japan
  • Translational Research Informatics Center, Foundation Biomedical Research and Innovation, Kobe, Hyogo, Japan
  • Department of Internal Medicine, Atsugi City Hospital, Atsugi, Kanagawa, Japan
  • Division of Nephrology, Toho University Ohashi Medical Center, Meguro, Tokyo, Japan
  • Department of Health Care Administration and Management, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Fukuoka, Japan
  • Nakayamadera Imai Clinic, Takarazuka, Hyogo, Department of Nephrology, Fujita Health University Toyoake, Toyoake, Aichi, Japan
  • Mitsukoshi Health and Welfare Foundation, Shinjuku, Tokyo, Japan
  • Department of Computer and Information Science, Seikei University, Musashino, Tokyo, Japan
  • Division of Nephrology, Department of Medicine, Showa University School of Medicine, Shinagawa, Tokyo, Japan
  • Course of Safety Management in Health Care Sciences, Graduate School of Health Care Sciences, Jikei Institute, Yodogawa, Osaka, Japan
  • Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan
  • Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Niigata, Japan
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/s10157-017-1427-4

    DOI

    http://dx.doi.org/10.1007/s10157-017-1427-4

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1090286267

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/28660446


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Clinical Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Aged, 80 and over", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Anemia", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Biomarkers", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Darbepoetin alfa", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Drug Resistance", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Female", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Glomerular Filtration Rate", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Hematinics", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Hemoglobins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Male", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Middle Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Observational Studies as Topic", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Patient Selection", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Prospective Studies", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Renal Insufficiency, Chronic", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Research Design", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Division of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo, 113-8655, Tokyo, Japan", 
              "id": "http://www.grid.ac/institutes/grid.26999.3d", 
              "name": [
                "Division of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo, 113-8655, Tokyo, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kato", 
            "givenName": "Hideki", 
            "id": "sg:person.01275753007.55", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01275753007.55"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Division of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo, 113-8655, Tokyo, Japan", 
              "id": "http://www.grid.ac/institutes/grid.26999.3d", 
              "name": [
                "Division of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo, 113-8655, Tokyo, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Nangaku", 
            "givenName": "Masaomi", 
            "id": "sg:person.01300062465.65", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01300062465.65"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Fukuoka Renal Clinic, Fukuoka, Fukuoka, Japan", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Fukuoka Renal Clinic, Fukuoka, Fukuoka, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Hirakata", 
            "givenName": "Hideki", 
            "id": "sg:person.0621372646.19", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0621372646.19"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Nephrology and Laboratory Medicine, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan", 
              "id": "http://www.grid.ac/institutes/grid.9707.9", 
              "name": [
                "Department of Nephrology and Laboratory Medicine, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Wada", 
            "givenName": "Takashi", 
            "id": "sg:person.0736010402.16", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0736010402.16"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Kidney Disease and Hypertension, Osaka General Medical Centre, Sumiyoshi, Osaka, Japan", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Department of Kidney Disease and Hypertension, Osaka General Medical Centre, Sumiyoshi, Osaka, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Hayashi", 
            "givenName": "Terumasa", 
            "id": "sg:person.01113653173.43", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01113653173.43"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Division of Clinical Pharmacology and Therapeutics, Tohoku University Graduate School of Pharmaceutical Sciences and Faculty of Pharmaceutical Sciences, Sendai, Miyagi, Japan", 
              "id": "http://www.grid.ac/institutes/grid.69566.3a", 
              "name": [
                "Division of Clinical Pharmacology and Therapeutics, Tohoku University Graduate School of Pharmaceutical Sciences and Faculty of Pharmaceutical Sciences, Sendai, Miyagi, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Sato", 
            "givenName": "Hiroshi", 
            "id": "sg:person.01072667343.29", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01072667343.29"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Nephrology and Rheumatology, Kagawa Prefectural Central Hospital, Takamatsu, Kagawa, Japan", 
              "id": "http://www.grid.ac/institutes/grid.414811.9", 
              "name": [
                "Department of Nephrology and Rheumatology, Kagawa Prefectural Central Hospital, Takamatsu, Kagawa, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Yamazaki", 
            "givenName": "Yasushi", 
            "id": "sg:person.015725276203.38", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015725276203.38"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Nephrology, Hiroshima University Hospital, Hiroshima, Hiroshima, Japan", 
              "id": "http://www.grid.ac/institutes/grid.470097.d", 
              "name": [
                "Department of Nephrology, Hiroshima University Hospital, Hiroshima, Hiroshima, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Masaki", 
            "givenName": "Takao", 
            "id": "sg:person.01214554415.96", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01214554415.96"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Translational Research Informatics Center, Foundation Biomedical Research and Innovation, Kobe, Hyogo, Japan", 
              "id": "http://www.grid.ac/institutes/grid.417982.1", 
              "name": [
                "Translational Research Informatics Center, Foundation Biomedical Research and Innovation, Kobe, Hyogo, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kagimura", 
            "givenName": "Tatsuo", 
            "id": "sg:person.01156504371.11", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01156504371.11"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Internal Medicine, Atsugi City Hospital, Atsugi, Kanagawa, Japan", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Department of Internal Medicine, Atsugi City Hospital, Atsugi, Kanagawa, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Yamamoto", 
            "givenName": "Hiroyasu", 
            "id": "sg:person.01017244414.13", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017244414.13"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Division of Nephrology, Toho University Ohashi Medical Center, Meguro, Tokyo, Japan", 
              "id": "http://www.grid.ac/institutes/grid.470115.6", 
              "name": [
                "Division of Nephrology, Toho University Ohashi Medical Center, Meguro, Tokyo, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Hase", 
            "givenName": "Hiroki", 
            "id": "sg:person.01231610312.43", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01231610312.43"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Health Care Administration and Management, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Fukuoka, Japan", 
              "id": "http://www.grid.ac/institutes/grid.177174.3", 
              "name": [
                "Department of Health Care Administration and Management, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Fukuoka, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kamouchi", 
            "givenName": "Masahiro", 
            "id": "sg:person.01077237461.22", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01077237461.22"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Nakayamadera Imai Clinic, Takarazuka, Hyogo, Department of Nephrology, Fujita Health University Toyoake, Toyoake, Aichi, Japan", 
              "id": "http://www.grid.ac/institutes/grid.256115.4", 
              "name": [
                "Nakayamadera Imai Clinic, Takarazuka, Hyogo, Department of Nephrology, Fujita Health University Toyoake, Toyoake, Aichi, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Imai", 
            "givenName": "Enyu", 
            "id": "sg:person.01067075364.77", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01067075364.77"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Mitsukoshi Health and Welfare Foundation, Shinjuku, Tokyo, Japan", 
              "id": "http://www.grid.ac/institutes/grid.490945.5", 
              "name": [
                "Mitsukoshi Health and Welfare Foundation, Shinjuku, Tokyo, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Mizuno", 
            "givenName": "Kyoichi", 
            "id": "sg:person.01224612517.39", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01224612517.39"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Computer and Information Science, Seikei University, Musashino, Tokyo, Japan", 
              "id": "http://www.grid.ac/institutes/grid.263319.c", 
              "name": [
                "Department of Computer and Information Science, Seikei University, Musashino, Tokyo, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Iwasaki", 
            "givenName": "Manabu", 
            "id": "sg:person.011477513361.44", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011477513361.44"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Division of Nephrology, Department of Medicine, Showa University School of Medicine, Shinagawa, Tokyo, Japan", 
              "id": "http://www.grid.ac/institutes/grid.410714.7", 
              "name": [
                "Division of Nephrology, Department of Medicine, Showa University School of Medicine, Shinagawa, Tokyo, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Akizawa", 
            "givenName": "Tadao", 
            "id": "sg:person.01026360545.50", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01026360545.50"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Course of Safety Management in Health Care Sciences, Graduate School of Health Care Sciences, Jikei Institute, Yodogawa, Osaka, Japan", 
              "id": "http://www.grid.ac/institutes/grid.458430.e", 
              "name": [
                "Course of Safety Management in Health Care Sciences, Graduate School of Health Care Sciences, Jikei Institute, Yodogawa, Osaka, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Tsubakihara", 
            "givenName": "Yoshiharu", 
            "id": "sg:person.01143640200.08", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01143640200.08"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan", 
              "id": "http://www.grid.ac/institutes/grid.27476.30", 
              "name": [
                "Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Maruyama", 
            "givenName": "Shoichi", 
            "id": "sg:person.01106355134.42", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01106355134.42"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Niigata, Japan", 
              "id": "http://www.grid.ac/institutes/grid.260975.f", 
              "name": [
                "Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Niigata, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Narita", 
            "givenName": "Ichiei", 
            "id": "sg:person.01137437756.61", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01137437756.61"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1186/s41100-017-0114-y", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1085936645", 
              "https://doi.org/10.1186/s41100-017-0114-y"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s10157-009-0199-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1018033692", 
              "https://doi.org/10.1007/s10157-009-0199-x"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s10157-014-0949-2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1044348895", 
              "https://doi.org/10.1007/s10157-014-0949-2"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/hr.2011.96", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1044206817", 
              "https://doi.org/10.1038/hr.2011.96"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s10157-010-0328-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1019009128", 
              "https://doi.org/10.1007/s10157-010-0328-6"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2017-06-28", 
        "datePublishedReg": "2017-06-28", 
        "description": "BackgroundRenal anemia is an important complication in non-dialysis chronic kidney disease (CKD) patients as well as in dialysis patients. Although recombinant human erythropoietin has dramatically improved prognosis and quality of life in these patients, there have been issues among non-dialysis CKD patients who exhibit hyporesponsiveness to erythropoiesis-stimulating agent (ESA). The causes and definition of ESA hyporesponsiveness, as well as the incidence of renal and cardiovascular disease (CVD) events in such patients, are yet to be clarified.MethodsThis ongoing trial is a multicenter, prospective, observational study of non-dialysis CKD patients with renal anemia. The primary objective is to survey the current realities of the therapy with ESA in Japan and evaluate the correlation between hyporesponsiveness to darbepoetin alfa and CKD progression. The secondary objective is to investigate relationship between ESA hyporesponsiveness and CVD events based on the clinical situation in Japan, and to explore an ESA response index.ResultsThe subjects consist of CKD patients with estimated glomerular filtration rate (eGFR) below 60\u00a0mL/min/1.73\u00a0m2 who present renal anemia. The target number of registered cases is 2000 patients, based on estimates of incidences of renal and CVD events from past studies. Renal function and CVD events will be observed for 96\u00a0weeks after the initiation of darbepoetin alfa administration. Definitions of ESA hyporesponsiveness will also be investigated.ConclusionBy clarifying markers and factors involved in ESA hyporesponsiveness and their relationships with renal and CVD events, this ongoing study aims to improve evidence-based therapies for renal anemia in non-dialysis CKD patients.", 
        "genre": "article", 
        "id": "sg:pub.10.1007/s10157-017-1427-4", 
        "isAccessibleForFree": true, 
        "isPartOf": [
          {
            "id": "sg:journal.1117096", 
            "issn": [
              "1342-1751", 
              "1437-7799"
            ], 
            "name": "Clinical and Experimental Nephrology", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "1", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "22"
          }
        ], 
        "keywords": [
          "non-dialysis CKD patients", 
          "erythropoiesis-stimulating agents", 
          "chronic kidney disease patients", 
          "kidney disease patients", 
          "ESA hyporesponsiveness", 
          "CKD patients", 
          "CVD events", 
          "renal anemia", 
          "disease patients", 
          "non-dialysis chronic kidney disease patients", 
          "darbepoetin alfa administration", 
          "cardiovascular disease events", 
          "glomerular filtration rate", 
          "evidence-based therapies", 
          "observational clinical research", 
          "estimates of incidence", 
          "recombinant human erythropoietin", 
          "quality of life", 
          "CKD progression", 
          "renal prognosis", 
          "renal function", 
          "important complication", 
          "dialysis patients", 
          "such patients", 
          "ongoing trials", 
          "darbepoetin alfa", 
          "filtration rate", 
          "observational study", 
          "hyporesponsive anemia", 
          "hyporesponsiveness", 
          "disease events", 
          "patients", 
          "anemia", 
          "clinical situations", 
          "human erythropoietin", 
          "secondary objective", 
          "clinical research", 
          "prognosis", 
          "therapy", 
          "alfa", 
          "ongoing studies", 
          "incidence", 
          "primary objective", 
          "multicenter", 
          "response index", 
          "complications", 
          "agents", 
          "administration", 
          "trials", 
          "progression", 
          "weeks", 
          "erythropoietin", 
          "study", 
          "events", 
          "markers", 
          "cause", 
          "target number", 
          "subjects", 
          "ConclusionBy", 
          "initiation", 
          "objective", 
          "rationale", 
          "index", 
          "factors", 
          "cases", 
          "relationship", 
          "life", 
          "rate", 
          "correlation", 
          "Japan", 
          "m2", 
          "past studies", 
          "function", 
          "definition", 
          "quality", 
          "number", 
          "research", 
          "situation", 
          "estimates", 
          "current reality", 
          "issues", 
          "design", 
          "reality"
        ], 
        "name": "Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial)", 
        "pagination": "78-84", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1090286267"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/s10157-017-1427-4"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "28660446"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/s10157-017-1427-4", 
          "https://app.dimensions.ai/details/publication/pub.1090286267"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-09-02T16:00", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_731.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1007/s10157-017-1427-4"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10157-017-1427-4'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10157-017-1427-4'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10157-017-1427-4'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10157-017-1427-4'


     

    This table displays all metadata directly associated to this object as RDF triples.

    411 TRIPLES      21 PREDICATES      131 URIs      118 LITERALS      25 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/s10157-017-1427-4 schema:about N13068dd893e841c3947bf589f6f5d2a1
    2 N2b5f8092f0334cd99a11e15cea305325
    3 N376f3e887f064283a76d82828b26e870
    4 N38139ee4dac34b819d5bae5dfa5bdfc0
    5 N5c8942f094504f9d9915414dd53fb8f1
    6 N866d71c0fa044ca08cc69eade30fa8a7
    7 N89c0c429a7fb48569692536967f0de87
    8 N8da1f1957f5c4c2590a390340f6dc18f
    9 Na0b6a7b2eb1845c3ac3c407ef17c7213
    10 Na502d4dd012e48f38bd5aeca589d30a4
    11 Na736d32d60fe44afb5b48351a9555fc2
    12 Nb4110ed89a3c4b3096d4287a3e70a3c4
    13 Nbc46137a3db048b1b7d7b3e4ddec2342
    14 Nbeff7f15262041f1a1f08dd92958494d
    15 Nc10ebc05c9954dd78a64e3b9435b2f7f
    16 Nca687596dc3c464b928f8cd3aede3cc9
    17 Nd0afb97d884543f98c63bedb5d2b2aa6
    18 Nd28d859703304698a4d9465304ffe0ab
    19 anzsrc-for:11
    20 anzsrc-for:1103
    21 schema:author Ncd14d29f386149e681243ab861549e4a
    22 schema:citation sg:pub.10.1007/s10157-009-0199-x
    23 sg:pub.10.1007/s10157-010-0328-6
    24 sg:pub.10.1007/s10157-014-0949-2
    25 sg:pub.10.1038/hr.2011.96
    26 sg:pub.10.1186/s41100-017-0114-y
    27 schema:datePublished 2017-06-28
    28 schema:datePublishedReg 2017-06-28
    29 schema:description BackgroundRenal anemia is an important complication in non-dialysis chronic kidney disease (CKD) patients as well as in dialysis patients. Although recombinant human erythropoietin has dramatically improved prognosis and quality of life in these patients, there have been issues among non-dialysis CKD patients who exhibit hyporesponsiveness to erythropoiesis-stimulating agent (ESA). The causes and definition of ESA hyporesponsiveness, as well as the incidence of renal and cardiovascular disease (CVD) events in such patients, are yet to be clarified.MethodsThis ongoing trial is a multicenter, prospective, observational study of non-dialysis CKD patients with renal anemia. The primary objective is to survey the current realities of the therapy with ESA in Japan and evaluate the correlation between hyporesponsiveness to darbepoetin alfa and CKD progression. The secondary objective is to investigate relationship between ESA hyporesponsiveness and CVD events based on the clinical situation in Japan, and to explore an ESA response index.ResultsThe subjects consist of CKD patients with estimated glomerular filtration rate (eGFR) below 60 mL/min/1.73 m2 who present renal anemia. The target number of registered cases is 2000 patients, based on estimates of incidences of renal and CVD events from past studies. Renal function and CVD events will be observed for 96 weeks after the initiation of darbepoetin alfa administration. Definitions of ESA hyporesponsiveness will also be investigated.ConclusionBy clarifying markers and factors involved in ESA hyporesponsiveness and their relationships with renal and CVD events, this ongoing study aims to improve evidence-based therapies for renal anemia in non-dialysis CKD patients.
    30 schema:genre article
    31 schema:isAccessibleForFree true
    32 schema:isPartOf N106aa7ebf3a3431b868f7aff67d0fff3
    33 Ne695da9125064bb0ab8de597624c5efe
    34 sg:journal.1117096
    35 schema:keywords CKD patients
    36 CKD progression
    37 CVD events
    38 ConclusionBy
    39 ESA hyporesponsiveness
    40 Japan
    41 administration
    42 agents
    43 alfa
    44 anemia
    45 cardiovascular disease events
    46 cases
    47 cause
    48 chronic kidney disease patients
    49 clinical research
    50 clinical situations
    51 complications
    52 correlation
    53 current reality
    54 darbepoetin alfa
    55 darbepoetin alfa administration
    56 definition
    57 design
    58 dialysis patients
    59 disease events
    60 disease patients
    61 erythropoiesis-stimulating agents
    62 erythropoietin
    63 estimates
    64 estimates of incidence
    65 events
    66 evidence-based therapies
    67 factors
    68 filtration rate
    69 function
    70 glomerular filtration rate
    71 human erythropoietin
    72 hyporesponsive anemia
    73 hyporesponsiveness
    74 important complication
    75 incidence
    76 index
    77 initiation
    78 issues
    79 kidney disease patients
    80 life
    81 m2
    82 markers
    83 multicenter
    84 non-dialysis CKD patients
    85 non-dialysis chronic kidney disease patients
    86 number
    87 objective
    88 observational clinical research
    89 observational study
    90 ongoing studies
    91 ongoing trials
    92 past studies
    93 patients
    94 primary objective
    95 prognosis
    96 progression
    97 quality
    98 quality of life
    99 rate
    100 rationale
    101 reality
    102 recombinant human erythropoietin
    103 relationship
    104 renal anemia
    105 renal function
    106 renal prognosis
    107 research
    108 response index
    109 secondary objective
    110 situation
    111 study
    112 subjects
    113 such patients
    114 target number
    115 therapy
    116 trials
    117 weeks
    118 schema:name Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial)
    119 schema:pagination 78-84
    120 schema:productId N72ab9aedfda140558bc5ce8180b8c869
    121 Na4d8cb3e01fd4ef792f30e291f2d781e
    122 Nac0d056093964525bc56a12eede8671b
    123 schema:sameAs https://app.dimensions.ai/details/publication/pub.1090286267
    124 https://doi.org/10.1007/s10157-017-1427-4
    125 schema:sdDatePublished 2022-09-02T16:00
    126 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    127 schema:sdPublisher Ne24555499d3347eda88666cad28e9de9
    128 schema:url https://doi.org/10.1007/s10157-017-1427-4
    129 sgo:license sg:explorer/license/
    130 sgo:sdDataset articles
    131 rdf:type schema:ScholarlyArticle
    132 N104614b4b1964e92bed0f009f4e4c39e rdf:first sg:person.01137437756.61
    133 rdf:rest rdf:nil
    134 N106aa7ebf3a3431b868f7aff67d0fff3 schema:volumeNumber 22
    135 rdf:type schema:PublicationVolume
    136 N13068dd893e841c3947bf589f6f5d2a1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    137 schema:name Renal Insufficiency, Chronic
    138 rdf:type schema:DefinedTerm
    139 N2b5f8092f0334cd99a11e15cea305325 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    140 schema:name Humans
    141 rdf:type schema:DefinedTerm
    142 N376f3e887f064283a76d82828b26e870 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    143 schema:name Darbepoetin alfa
    144 rdf:type schema:DefinedTerm
    145 N38139ee4dac34b819d5bae5dfa5bdfc0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    146 schema:name Aged, 80 and over
    147 rdf:type schema:DefinedTerm
    148 N4e9701df28994ebfab4b0a375cc64a11 rdf:first sg:person.01072667343.29
    149 rdf:rest N6dc97330c99e4d62a72282e187905f69
    150 N524bb6286a34466fbe0d24a42fb16ffa rdf:first sg:person.01300062465.65
    151 rdf:rest Nbd3c2f9f664d42dd9de6927fc31f1e02
    152 N53b800a846bc4b738f2af10f0625cfa5 rdf:first sg:person.011477513361.44
    153 rdf:rest Nb27d26d0f2ad4e8c9e56c88647b637bb
    154 N580b0b577f8e40d590381cb848f244ab rdf:first sg:person.01017244414.13
    155 rdf:rest Nd5b066db1aef4835b3c5350537ec14f3
    156 N5c8942f094504f9d9915414dd53fb8f1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    157 schema:name Hemoglobins
    158 rdf:type schema:DefinedTerm
    159 N6b4dce9b718d4045be236e8c47635b61 rdf:first sg:person.0736010402.16
    160 rdf:rest N6b8e4380164b4ca984a8370fed14bf3a
    161 N6b8e4380164b4ca984a8370fed14bf3a rdf:first sg:person.01113653173.43
    162 rdf:rest N4e9701df28994ebfab4b0a375cc64a11
    163 N6dc97330c99e4d62a72282e187905f69 rdf:first sg:person.015725276203.38
    164 rdf:rest N97462403f6c94360b367744c9fa1eac1
    165 N72ab9aedfda140558bc5ce8180b8c869 schema:name dimensions_id
    166 schema:value pub.1090286267
    167 rdf:type schema:PropertyValue
    168 N76a91a484b6a4320a6a9953a01cb388b rdf:first sg:person.01077237461.22
    169 rdf:rest Nd39fdd09040741cbb2611a4e7e297a05
    170 N866d71c0fa044ca08cc69eade30fa8a7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    171 schema:name Drug Resistance
    172 rdf:type schema:DefinedTerm
    173 N89c0c429a7fb48569692536967f0de87 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    174 schema:name Middle Aged
    175 rdf:type schema:DefinedTerm
    176 N8da1f1957f5c4c2590a390340f6dc18f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    177 schema:name Anemia
    178 rdf:type schema:DefinedTerm
    179 N97462403f6c94360b367744c9fa1eac1 rdf:first sg:person.01214554415.96
    180 rdf:rest Nbf6042858b6f4b44b7490266390722dd
    181 N996be140956f43048e3c738bc1f2e9a6 rdf:first sg:person.01224612517.39
    182 rdf:rest N53b800a846bc4b738f2af10f0625cfa5
    183 Na0b6a7b2eb1845c3ac3c407ef17c7213 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    184 schema:name Female
    185 rdf:type schema:DefinedTerm
    186 Na4d8cb3e01fd4ef792f30e291f2d781e schema:name doi
    187 schema:value 10.1007/s10157-017-1427-4
    188 rdf:type schema:PropertyValue
    189 Na502d4dd012e48f38bd5aeca589d30a4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    190 schema:name Observational Studies as Topic
    191 rdf:type schema:DefinedTerm
    192 Na736d32d60fe44afb5b48351a9555fc2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    193 schema:name Aged
    194 rdf:type schema:DefinedTerm
    195 Nac0d056093964525bc56a12eede8671b schema:name pubmed_id
    196 schema:value 28660446
    197 rdf:type schema:PropertyValue
    198 Naf3138eeee314614b9dcfc849f29b618 rdf:first sg:person.01106355134.42
    199 rdf:rest N104614b4b1964e92bed0f009f4e4c39e
    200 Nb27d26d0f2ad4e8c9e56c88647b637bb rdf:first sg:person.01026360545.50
    201 rdf:rest Nf558e2a55c9746ef892dbbe88ca84500
    202 Nb4110ed89a3c4b3096d4287a3e70a3c4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    203 schema:name Research Design
    204 rdf:type schema:DefinedTerm
    205 Nbc46137a3db048b1b7d7b3e4ddec2342 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    206 schema:name Glomerular Filtration Rate
    207 rdf:type schema:DefinedTerm
    208 Nbd3c2f9f664d42dd9de6927fc31f1e02 rdf:first sg:person.0621372646.19
    209 rdf:rest N6b4dce9b718d4045be236e8c47635b61
    210 Nbeff7f15262041f1a1f08dd92958494d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    211 schema:name Prospective Studies
    212 rdf:type schema:DefinedTerm
    213 Nbf6042858b6f4b44b7490266390722dd rdf:first sg:person.01156504371.11
    214 rdf:rest N580b0b577f8e40d590381cb848f244ab
    215 Nc10ebc05c9954dd78a64e3b9435b2f7f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    216 schema:name Biomarkers
    217 rdf:type schema:DefinedTerm
    218 Nca687596dc3c464b928f8cd3aede3cc9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    219 schema:name Male
    220 rdf:type schema:DefinedTerm
    221 Ncd14d29f386149e681243ab861549e4a rdf:first sg:person.01275753007.55
    222 rdf:rest N524bb6286a34466fbe0d24a42fb16ffa
    223 Nd0afb97d884543f98c63bedb5d2b2aa6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    224 schema:name Hematinics
    225 rdf:type schema:DefinedTerm
    226 Nd28d859703304698a4d9465304ffe0ab schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    227 schema:name Patient Selection
    228 rdf:type schema:DefinedTerm
    229 Nd39fdd09040741cbb2611a4e7e297a05 rdf:first sg:person.01067075364.77
    230 rdf:rest N996be140956f43048e3c738bc1f2e9a6
    231 Nd5b066db1aef4835b3c5350537ec14f3 rdf:first sg:person.01231610312.43
    232 rdf:rest N76a91a484b6a4320a6a9953a01cb388b
    233 Ne24555499d3347eda88666cad28e9de9 schema:name Springer Nature - SN SciGraph project
    234 rdf:type schema:Organization
    235 Ne695da9125064bb0ab8de597624c5efe schema:issueNumber 1
    236 rdf:type schema:PublicationIssue
    237 Nf558e2a55c9746ef892dbbe88ca84500 rdf:first sg:person.01143640200.08
    238 rdf:rest Naf3138eeee314614b9dcfc849f29b618
    239 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    240 schema:name Medical and Health Sciences
    241 rdf:type schema:DefinedTerm
    242 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
    243 schema:name Clinical Sciences
    244 rdf:type schema:DefinedTerm
    245 sg:journal.1117096 schema:issn 1342-1751
    246 1437-7799
    247 schema:name Clinical and Experimental Nephrology
    248 schema:publisher Springer Nature
    249 rdf:type schema:Periodical
    250 sg:person.01017244414.13 schema:affiliation grid-institutes:None
    251 schema:familyName Yamamoto
    252 schema:givenName Hiroyasu
    253 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017244414.13
    254 rdf:type schema:Person
    255 sg:person.01026360545.50 schema:affiliation grid-institutes:grid.410714.7
    256 schema:familyName Akizawa
    257 schema:givenName Tadao
    258 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01026360545.50
    259 rdf:type schema:Person
    260 sg:person.01067075364.77 schema:affiliation grid-institutes:grid.256115.4
    261 schema:familyName Imai
    262 schema:givenName Enyu
    263 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01067075364.77
    264 rdf:type schema:Person
    265 sg:person.01072667343.29 schema:affiliation grid-institutes:grid.69566.3a
    266 schema:familyName Sato
    267 schema:givenName Hiroshi
    268 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01072667343.29
    269 rdf:type schema:Person
    270 sg:person.01077237461.22 schema:affiliation grid-institutes:grid.177174.3
    271 schema:familyName Kamouchi
    272 schema:givenName Masahiro
    273 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01077237461.22
    274 rdf:type schema:Person
    275 sg:person.01106355134.42 schema:affiliation grid-institutes:grid.27476.30
    276 schema:familyName Maruyama
    277 schema:givenName Shoichi
    278 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01106355134.42
    279 rdf:type schema:Person
    280 sg:person.01113653173.43 schema:affiliation grid-institutes:None
    281 schema:familyName Hayashi
    282 schema:givenName Terumasa
    283 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01113653173.43
    284 rdf:type schema:Person
    285 sg:person.01137437756.61 schema:affiliation grid-institutes:grid.260975.f
    286 schema:familyName Narita
    287 schema:givenName Ichiei
    288 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01137437756.61
    289 rdf:type schema:Person
    290 sg:person.01143640200.08 schema:affiliation grid-institutes:grid.458430.e
    291 schema:familyName Tsubakihara
    292 schema:givenName Yoshiharu
    293 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01143640200.08
    294 rdf:type schema:Person
    295 sg:person.011477513361.44 schema:affiliation grid-institutes:grid.263319.c
    296 schema:familyName Iwasaki
    297 schema:givenName Manabu
    298 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011477513361.44
    299 rdf:type schema:Person
    300 sg:person.01156504371.11 schema:affiliation grid-institutes:grid.417982.1
    301 schema:familyName Kagimura
    302 schema:givenName Tatsuo
    303 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01156504371.11
    304 rdf:type schema:Person
    305 sg:person.01214554415.96 schema:affiliation grid-institutes:grid.470097.d
    306 schema:familyName Masaki
    307 schema:givenName Takao
    308 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01214554415.96
    309 rdf:type schema:Person
    310 sg:person.01224612517.39 schema:affiliation grid-institutes:grid.490945.5
    311 schema:familyName Mizuno
    312 schema:givenName Kyoichi
    313 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01224612517.39
    314 rdf:type schema:Person
    315 sg:person.01231610312.43 schema:affiliation grid-institutes:grid.470115.6
    316 schema:familyName Hase
    317 schema:givenName Hiroki
    318 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01231610312.43
    319 rdf:type schema:Person
    320 sg:person.01275753007.55 schema:affiliation grid-institutes:grid.26999.3d
    321 schema:familyName Kato
    322 schema:givenName Hideki
    323 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01275753007.55
    324 rdf:type schema:Person
    325 sg:person.01300062465.65 schema:affiliation grid-institutes:grid.26999.3d
    326 schema:familyName Nangaku
    327 schema:givenName Masaomi
    328 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01300062465.65
    329 rdf:type schema:Person
    330 sg:person.015725276203.38 schema:affiliation grid-institutes:grid.414811.9
    331 schema:familyName Yamazaki
    332 schema:givenName Yasushi
    333 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015725276203.38
    334 rdf:type schema:Person
    335 sg:person.0621372646.19 schema:affiliation grid-institutes:None
    336 schema:familyName Hirakata
    337 schema:givenName Hideki
    338 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0621372646.19
    339 rdf:type schema:Person
    340 sg:person.0736010402.16 schema:affiliation grid-institutes:grid.9707.9
    341 schema:familyName Wada
    342 schema:givenName Takashi
    343 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0736010402.16
    344 rdf:type schema:Person
    345 sg:pub.10.1007/s10157-009-0199-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1018033692
    346 https://doi.org/10.1007/s10157-009-0199-x
    347 rdf:type schema:CreativeWork
    348 sg:pub.10.1007/s10157-010-0328-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019009128
    349 https://doi.org/10.1007/s10157-010-0328-6
    350 rdf:type schema:CreativeWork
    351 sg:pub.10.1007/s10157-014-0949-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044348895
    352 https://doi.org/10.1007/s10157-014-0949-2
    353 rdf:type schema:CreativeWork
    354 sg:pub.10.1038/hr.2011.96 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044206817
    355 https://doi.org/10.1038/hr.2011.96
    356 rdf:type schema:CreativeWork
    357 sg:pub.10.1186/s41100-017-0114-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1085936645
    358 https://doi.org/10.1186/s41100-017-0114-y
    359 rdf:type schema:CreativeWork
    360 grid-institutes:None schema:alternateName Department of Internal Medicine, Atsugi City Hospital, Atsugi, Kanagawa, Japan
    361 Department of Kidney Disease and Hypertension, Osaka General Medical Centre, Sumiyoshi, Osaka, Japan
    362 Fukuoka Renal Clinic, Fukuoka, Fukuoka, Japan
    363 schema:name Department of Internal Medicine, Atsugi City Hospital, Atsugi, Kanagawa, Japan
    364 Department of Kidney Disease and Hypertension, Osaka General Medical Centre, Sumiyoshi, Osaka, Japan
    365 Fukuoka Renal Clinic, Fukuoka, Fukuoka, Japan
    366 rdf:type schema:Organization
    367 grid-institutes:grid.177174.3 schema:alternateName Department of Health Care Administration and Management, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Fukuoka, Japan
    368 schema:name Department of Health Care Administration and Management, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Fukuoka, Japan
    369 rdf:type schema:Organization
    370 grid-institutes:grid.256115.4 schema:alternateName Nakayamadera Imai Clinic, Takarazuka, Hyogo, Department of Nephrology, Fujita Health University Toyoake, Toyoake, Aichi, Japan
    371 schema:name Nakayamadera Imai Clinic, Takarazuka, Hyogo, Department of Nephrology, Fujita Health University Toyoake, Toyoake, Aichi, Japan
    372 rdf:type schema:Organization
    373 grid-institutes:grid.260975.f schema:alternateName Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Niigata, Japan
    374 schema:name Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Niigata, Japan
    375 rdf:type schema:Organization
    376 grid-institutes:grid.263319.c schema:alternateName Department of Computer and Information Science, Seikei University, Musashino, Tokyo, Japan
    377 schema:name Department of Computer and Information Science, Seikei University, Musashino, Tokyo, Japan
    378 rdf:type schema:Organization
    379 grid-institutes:grid.26999.3d schema:alternateName Division of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo, 113-8655, Tokyo, Japan
    380 schema:name Division of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo, 113-8655, Tokyo, Japan
    381 rdf:type schema:Organization
    382 grid-institutes:grid.27476.30 schema:alternateName Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan
    383 schema:name Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan
    384 rdf:type schema:Organization
    385 grid-institutes:grid.410714.7 schema:alternateName Division of Nephrology, Department of Medicine, Showa University School of Medicine, Shinagawa, Tokyo, Japan
    386 schema:name Division of Nephrology, Department of Medicine, Showa University School of Medicine, Shinagawa, Tokyo, Japan
    387 rdf:type schema:Organization
    388 grid-institutes:grid.414811.9 schema:alternateName Department of Nephrology and Rheumatology, Kagawa Prefectural Central Hospital, Takamatsu, Kagawa, Japan
    389 schema:name Department of Nephrology and Rheumatology, Kagawa Prefectural Central Hospital, Takamatsu, Kagawa, Japan
    390 rdf:type schema:Organization
    391 grid-institutes:grid.417982.1 schema:alternateName Translational Research Informatics Center, Foundation Biomedical Research and Innovation, Kobe, Hyogo, Japan
    392 schema:name Translational Research Informatics Center, Foundation Biomedical Research and Innovation, Kobe, Hyogo, Japan
    393 rdf:type schema:Organization
    394 grid-institutes:grid.458430.e schema:alternateName Course of Safety Management in Health Care Sciences, Graduate School of Health Care Sciences, Jikei Institute, Yodogawa, Osaka, Japan
    395 schema:name Course of Safety Management in Health Care Sciences, Graduate School of Health Care Sciences, Jikei Institute, Yodogawa, Osaka, Japan
    396 rdf:type schema:Organization
    397 grid-institutes:grid.470097.d schema:alternateName Department of Nephrology, Hiroshima University Hospital, Hiroshima, Hiroshima, Japan
    398 schema:name Department of Nephrology, Hiroshima University Hospital, Hiroshima, Hiroshima, Japan
    399 rdf:type schema:Organization
    400 grid-institutes:grid.470115.6 schema:alternateName Division of Nephrology, Toho University Ohashi Medical Center, Meguro, Tokyo, Japan
    401 schema:name Division of Nephrology, Toho University Ohashi Medical Center, Meguro, Tokyo, Japan
    402 rdf:type schema:Organization
    403 grid-institutes:grid.490945.5 schema:alternateName Mitsukoshi Health and Welfare Foundation, Shinjuku, Tokyo, Japan
    404 schema:name Mitsukoshi Health and Welfare Foundation, Shinjuku, Tokyo, Japan
    405 rdf:type schema:Organization
    406 grid-institutes:grid.69566.3a schema:alternateName Division of Clinical Pharmacology and Therapeutics, Tohoku University Graduate School of Pharmaceutical Sciences and Faculty of Pharmaceutical Sciences, Sendai, Miyagi, Japan
    407 schema:name Division of Clinical Pharmacology and Therapeutics, Tohoku University Graduate School of Pharmaceutical Sciences and Faculty of Pharmaceutical Sciences, Sendai, Miyagi, Japan
    408 rdf:type schema:Organization
    409 grid-institutes:grid.9707.9 schema:alternateName Department of Nephrology and Laboratory Medicine, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan
    410 schema:name Department of Nephrology and Laboratory Medicine, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan
    411 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...